Abstract
The p38 Mitogen-Activated Protein (MAP) kinase, a serine/threonine kinase, is one of the best characterized kinases in the inflammatory process. Among the four identified p38 isoforms (p38α, p38β, p38γ, and p38δ), the -form is the most fully studied and plays a central role in the biosynthesis of the proinflammatory cytokines i.e. IL-1β and TNF-α at the translational and transcriptional levels. Antagonism of these proinflammatory cytokines has been recognized as an effective possibility for the development of new drug candidates. The characterization of the pharmacological profile displayed by the selective p38 inhibitor prototype SB203580, proved its disease-modifying activity in the adjuvantinduced arthritis model. This strongly suggests that adequate modulation of production of these cytokines can bring significant benefits to the therapy of chronic inflammatory diseases. In addition to its important role for the secretion of proinflammatory cytokines, p38 is also involved in the activation of matrix metalloproteinases and the induction of COX- 2 transcription, proteins that are involved in the process of tissue destruction and inflammation. Because of its multiple functions in modulating the inflammatory response, it is expected that p38 inhibiting drugs will treat the underlying cause of chronic inflammatory diseases and stop their progression. The archetypal small molecule p38 inhibitors are the pyridinylimidazoles and these structures formed the basis for much of the early research. More recently a number of nonimidazole based p38 inhibitors such as the ureas, pyrazoles, pyrazoloheteroaryls, pyridazines, indoles, amides, pyridines, triazolopyridines, etc containing a variety of functionality have been reported to inhibit cytokine activity. This article provides a critical account of these different heterocycles reported for p38 MAPK inhibition and covers the recent research in the development of anti inflammatory agents.
Keywords: Anti inflammatory, Imidazole, p38 inhibitors, Kinases, Urea, Pyrazolyl urea.
Mini-Reviews in Medicinal Chemistry
Title:p38 MAP Kinase Inhibitors as Anti inflammatory Agents
Volume: 13 Issue: 14
Author(s): Mohammad Amir, K. Somakala and Sazid Ali
Affiliation:
Keywords: Anti inflammatory, Imidazole, p38 inhibitors, Kinases, Urea, Pyrazolyl urea.
Abstract: The p38 Mitogen-Activated Protein (MAP) kinase, a serine/threonine kinase, is one of the best characterized kinases in the inflammatory process. Among the four identified p38 isoforms (p38α, p38β, p38γ, and p38δ), the -form is the most fully studied and plays a central role in the biosynthesis of the proinflammatory cytokines i.e. IL-1β and TNF-α at the translational and transcriptional levels. Antagonism of these proinflammatory cytokines has been recognized as an effective possibility for the development of new drug candidates. The characterization of the pharmacological profile displayed by the selective p38 inhibitor prototype SB203580, proved its disease-modifying activity in the adjuvantinduced arthritis model. This strongly suggests that adequate modulation of production of these cytokines can bring significant benefits to the therapy of chronic inflammatory diseases. In addition to its important role for the secretion of proinflammatory cytokines, p38 is also involved in the activation of matrix metalloproteinases and the induction of COX- 2 transcription, proteins that are involved in the process of tissue destruction and inflammation. Because of its multiple functions in modulating the inflammatory response, it is expected that p38 inhibiting drugs will treat the underlying cause of chronic inflammatory diseases and stop their progression. The archetypal small molecule p38 inhibitors are the pyridinylimidazoles and these structures formed the basis for much of the early research. More recently a number of nonimidazole based p38 inhibitors such as the ureas, pyrazoles, pyrazoloheteroaryls, pyridazines, indoles, amides, pyridines, triazolopyridines, etc containing a variety of functionality have been reported to inhibit cytokine activity. This article provides a critical account of these different heterocycles reported for p38 MAPK inhibition and covers the recent research in the development of anti inflammatory agents.
Export Options
About this article
Cite this article as:
Amir Mohammad, Somakala K. and Ali Sazid, p38 MAP Kinase Inhibitors as Anti inflammatory Agents, Mini-Reviews in Medicinal Chemistry 2013; 13 (14) . https://dx.doi.org/10.2174/13895575113136660098
DOI https://dx.doi.org/10.2174/13895575113136660098 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting miRNAs for Drug Discovery: A New Paradigm
Current Molecular Medicine Fenugreek Cultivation with Emphasis on Historical Aspects and its uses in Traditional Medicine and Modern Pharmaceutical Science
Mini-Reviews in Medicinal Chemistry Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review
Current Diabetes Reviews Indications of Anti-Inflammatory Drugs in Cardiac Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Gut-Brain Axis in Gastric Mucosal Damage and Protection
Current Neuropharmacology Fatty Acids and Herbal Medicine
Current Traditional Medicine Azimilide, A Novel Oral Class III Antiarrhythmic for Both Supraventricular and Ventricular Arrhythmias
Current Drug Targets - Cardiovascular & Hematological Disorders Outcomes of Patients with Chronic Heart Failure and Iron Deficiency Treated with Intravenous Iron: A Meta-analysis
Cardiovascular & Hematological Disorders-Drug Targets Potential Application of Dietary Polyphenols from Red Wine to Attaining Healthy Ageing
Current Topics in Medicinal Chemistry Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery
Current Drug Targets Anti-inflammatory Glycosylated Flavonoids as Therapeutic Agents for Treatment of Diabetes-Impaired Wounds
Current Topics in Medicinal Chemistry Network based Approach to Drug Discovery: A Mini Review
Mini-Reviews in Medicinal Chemistry In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides
Current Pharmaceutical Design Arachidonate Cascade in the Intensive Insulin Therapy for Critically Ill Patients with Sepsis: Roles of Prostaglandins on Hyperglycemia-Impaired Immunity
Letters in Drug Design & Discovery Phytotherapeutic and Natural Compound Applications for Age-Related, Inflammatory and Serious Eye Ailments
Current Molecular Pharmacology Phospholipase D Inhibition: Beneficial and Harmful Consequences for a Double-Dealer Enzyme
Current Enzyme Inhibition Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease
Current Medicinal Chemistry Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
Current Gene Therapy Natural Phenolic Compounds as Cardiovascular Therapeutics: Potential Role of their Antiinflammatory Effects
Current Vascular Pharmacology Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology